Validation of AI-Based Medical Devices: Balancing Innovation and EU Regulations 

Artificial Intelligence (AI) is driving a major technological shift in healthcare, enhancing diagnosis, patient monitoring, and treatment. However, its adoption also requires a careful evaluation of regulatory responsibilities and safety requirements. 

What EU regulations apply to AI-based medical devices? 

The current European regulatory framework is built around three key pillars: 

• Medical Device Regulation (MDR 2017/745) 

• In Vitro Diagnostic Regulation (IVDR) 

• Artificial Intelligence Act (AIA) 

The AIA introduces specific rules for AI systems, especially those classified as high-risk, including many MedTech solutions. 

How is the risk of an AI-powered medical device classified? 

Risk classification is based on the potential impact on patient health and safety. Devices that support clinical decisions or automate diagnostic or therapeutic processes typically fall under the high-risk category, as defined by the AI Act. 

How are accuracy, robustness, and cybersecurity ensured in AI devices? 

European regulations require AI-based medical devices to guarantee not only high performance, but also strict compliance with data Confidentiality, Integrity, and Availability (CIA). Key requirements include: 

• Algorithmic transparency 

• Human oversight across the device lifecycle 

• Built-in cybersecurity safeguards 

This technical insight by Teoresi MedTech offers a concise yet comprehensive overview of the core principles outlined in the MDR, IVDR, and AIA. It serves as a valuable resource for manufacturers, designers, QA/RA teams, and MedTech stakeholders navigating the intersection of innovation and compliance. 

Want to know more? Download the entire article here below!